Lipidomics : comprehensive mass spectrometry of lipids /

Bibliographic Details
Main Author:	Han, Xianlin
Format:	eBook
Language:	English
Published:	Hoboken, New Jersey : Wiley, [2016]
Subjects:	Lipids > Analysis. Lipids > Spectra. Mass spectrometry. Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

FOREWORD xix; PREFACE xxi; ABBREVIATIONS xxv; ; PART I INTRODUCTION 1; 1 Lipids and Lipidomics 3; 1.1 Lipids, 3; 1.1.1 Definition, 3; 1.1.2 Classification, 4; 1.1.2.1 Lipid MAPS Approach, 7; 1.1.2.2 Building Block Approach, 10; 1.2 Lipidomics, 13; 1.2.1 Definition, 13; 1.2.2 History of Lipidomics, 14; References, 16; ; 2 Mass Spectrometry for Lipidomics 21; 2.1 Ionization Techniques, 21; 2.1.1 Electrospray Ionization, 22; 2.1.1.1 Principle of Electrospray Ionization, 22; 2.1.1.2 Features of Electrospray Ionization for Lipid Analysis, 28; 2.1.1.3 Advent of ESI for Lipid Analysis: Nano-ESI and Off-Axis Ion Inlets, 30; 2.1.2 Matrix-Assisted Laser Desorption/Ionization, 30; 2.2 Mass Analyzers, 32; 2.2.1 Quadrupole, 32; 2.2.2 Time of Flight, 33; 2.2.3 Ion Trap, 35; 2.3 Detector, 36; 2.4 Tandem Mass Spectrometry Techniques, 37; 2.4.1 Product-Ion Analysis,
37; 2.4.2 Neutral-Loss Scan, 39; 2.4.3 Precursor-Ion Scan, 39; 2.4.4 Selected Reaction Monitoring, 39; 2.4.5 Interweaving Tandem Mass Spectrometry Techniques, 40; 2.5 Other Recent Advances in Mass Spectrometry for Lipid Analysis, 42; 2.5.1 Ion-Mobility Mass Spectrometry, 43; 2.5.2 Desorption Electrospray Ionization, 43; References, 45; ; 3 Mass Spectrometry-Based Lipidomics Approaches 53; 3.1 Introduction, 53; 3.2 Shotgun Lipidomics: Direct Infusion-Based Approaches, 54; 3.2.1 Devices for Direct Infusion, 54; 3.2.2 Features of Shotgun Lipidomics, 55; 3.2.3 Shotgun Lipidomics Approaches, 56; 3.2.3.1 Tandem Mass Spectrometry-Based Shotgun Lipidomics, 56; 3.2.3.2 High Mass Accuracy-Based Shotgun Lipidomics, 56; 3.2.3.3 Multidimensional MS-Based Shotgun Lipidomics, 57; 3.2.4 Advantages and Drawbacks, 63; 3.2.4.1 Tandem Mass Spectrometry-Based Shotgun Lipidomics,
63; 3.2.4.2 High Mass Accuracy-Based Shotgun Lipidomics, 63; 3.2.4.3 Multidimensional Mass Spectrometry-Based Shotgun Lipidomics, 64; 3.3 LC-MS-Based Approaches, 65; 3.3.1 General, 65; 3.3.1.1 Selected Ion Monitoring for LC-MS, 66; 3.3.1.2 Selected/Multiple Reaction Monitoring for LC-MS, 67; 3.3.1.3 Data-Dependent Analysis after LC-MS, 67; 3.3.2 LC-MS-Based Approaches for Lipidomics, 68; 3.3.2.1 Normal-Phase LC-MS-Based Approaches, 68; 3.3.2.2 Reversed-Phase LC-MS-Based Approaches, 69; 3.3.2.3 Hydrophilic Interaction LC-MS-Based Approaches, 71; 3.3.2.4 Other LC-MS-Based Approaches, 72; 3.3.3 Advantages and Drawbacks, 72; 3.3.4 Identification of Lipid Species after LC-MS, 73; 3.4 MALDI-MS for Lipidomics, 74; 3.4.1 General, 74; 3.4.2 Analysis of Lipid Extracts, 74; 3.4.3 Advantages and Drawbacks, 75; 3.4.4 Recent Advances in MALDI-MS for Lipidomics, 76; 3.4.4.1 Utilization of Novel Matrices,
76; 3.4.4.2 (HP)TLC-MALDI-MS, 78; 3.4.4.3 Matrix-Free Laser Desorption/Ionization; Approaches, 78; References, 79; ; 4 Variables in Mass Spectrometry for Lipidomics 89; 4.1 Introduction, 89; 4.2 Variables in Lipid Extraction (i.e., Multiplex Extraction Conditions), 89; 4.2.1 The pH Conditions of Lipid Extraction, 89; 4.2.2 Solvent Polarity of Lipid Extraction, 90; 4.2.3 Intrinsic Chemical Properties of Lipids, 90; 4.3 Variables in the Infusion Solution, 91; 4.3.1 Polarity, Composition, Ion Pairing, and Other Variations in the Infusion Solution, 91; 4.3.2 Variations of the Levels or Composition of a Modifier in the Infusion Solution, 93; 4.3.3 Lipid Concentration in the Infusion Solution, 97; 4.4 Variables in Ionization, 98; 4.4.1 Source Temperature, 98; 4.4.2 Spray Voltage, 99; 4.4.3 Injection/Eluent Flow Rate, 100; 4.5 Variables in Building-Block monitoring with MS/MS Scanning,
102; 4.5.1 Precursor-Ion Scanning of a Fragment Ion Whose m/z Serves as a Variable, 102; 4.5.2 Neutral-Loss Scanning of a Neutral Fragment Whose Mass Serves as a Variable, 102; 4.5.3 Fragments Associated with the Building Blocks are the Variables in Product-Ion MS Analysis, 103; 4.6 Variables in Collision, 104; 4.6.1 Collision Energy, 104; 4.6.2 Collision-Gas Pressure, 104; 4.6.3 Collision Gas Type, 108; 4.7 Variables in Separation, 108; 4.7.1 Charge Properties in Intrasource Separation, 108; 4.7.2 Elution Time in LC Separation, 111; 4.7.3 Matrix Properties in Selective Ionization by MALDI, 112; 4.7.4 Drift Time (or Collision Cross Section) in Ion-Mobility Separation, 112; 4.8 Conclusion, 114; References, 114; ; 5 Bioinformatics in Lipidomics 121; 5.1 Introduction, 121; 5.2 Lipid Libraries and Databases, 122; 5.2.1 Lipid MAPS Structure Database,
139; 5.4.2 Simulation of Lipidomics Data for Interpretation of Biosynthesis Pathways, 140; 5.4.3 Modeling of Spatial Distributions and Biophysical; 5.5 Integration of Omics, 143; 5.5.1 Integration of Lipidomics with Other Omics, 143; 5.5.2 Lipidomics Guides Genomics Analysis, 144; References, 145; ; PART II CHARACTERIZATION OF LIPIDS 151; 6 Introduction 153; 6.1 Structural Characterization for Lipid Identification, 153; 6.2 Pattern Recognition for Lipid Identification, 157; 6.2.1 Principles of Pattern Recognition, 157; 6.2.2 Examples, 159; 6.2.2.1 Choline Lysoglycerophospholipid, 159; 6.2.2.2 Sphingomyelin, 161; 6.2.2.3 Triacylglycerol, 164; 6.2.3 Summary, 169; References, 170; ; 7 Fragmentation Patterns of Glycerophospholipids 173; 7.1 Introduction, 173; 7.2 Choline Glycerophospholipid, 175; 7.2.1 Positive Ion Mode, 175; 7.2.1.1 Protonated Species, 175; 7.2.1.2 Alkaline Adducts,
175; 7.2.2 Negative-Ion Mode, 178; 7.3 Ethanolamine Glycerophospholipid, 180; 7.3.1 Positive-Ion Mode, 180; 7.3.1.1 Protonated Species, 180; 7.3.1.2 Alkaline Adducts, 180; 7.3.2 Negative-Ion Mode, 182; 7.3.2.1 Deprotonated Species, 182; 7.3.2.2 Derivatized Species, 183; 7.4 Phosphatidylinositol and Phosphatidylinositides, 184; 7.4.1 Positive-Ion Mode, 184; 7.4.2 Negative-Ion Mode, 184; 7.5 Phosphatidylserine, 185; 7.5.1 Positive-Ion Mode, 185; 7.5.2 Negative-Ion Mode, 186; 7.6 Phosphatidylglycerol, 186; 7.6.1 Positive-Ion Mode, 186; 7.6.2 Negative-Ion Mode, 186; 7.7 Phosphatidic Acid, 187; 7.7.1 Positive-Ion Mode, 187; 7.7.2 Negative-Ion Mode, 188; 7.8 Cardiolipin, 188; 7.9 Lysoglycerophospholipids, 190; 7.9.1 Choline Lysoglycerophospholipids, 190; 7.9.2 Ethanolamine Lysoglycerophospholipids, 191; 7.9.3 Anionic Lysoglycerophospholipids, 193; 7.10 Other Glycerophospholipids,
193; 7.10.1 N-Acyl Phosphatidylethanolamine, 193; 7.10.2 N-Acyl Phosphatidylserine, 194; 7.10.3 Acyl Phosphatidylglycerol, 194; 7.10.4 Bis(monoacylglycero)phosphate, 194; 7.10.5 Cyclic Phosphatidic Acid, 196; References, 196; ; 8 Fragmentation Patterns of Sphingolipids 201; 8.1 Introduction, 201; 8.2 Ceramide, 202; 8.2.1 Positive-Ion Mode, 202; 8.2.2 Negative-Ion Mode, 203; 8.3 Sphingomyelin, 205; 8.3.1 Positive-Ion Mode, 205; 8.3.2 Negative-Ion Mode, 205; 8.4 Cerebroside, 205; 8.4.1 Positive-Ion Mode, 205; 8.4.2 Negative-Ion Mode, 207; 8.5 Sulfatide, 208; 8.6 Oligoglycosylceramide and Gangliosides, 208; 8.7 Inositol Phosphorylceramide, 210; 8.8 Sphingolipid Metabolites, 210; 8.8.1 Sphingoid Bases, 210; 8.8.2 Sphingoid-1-Phosphate, 212; 8.8.3 Lysosphingomyelin, 212; 8.8.4 Psychosine, 213; References, 213; ; 9 Fragmentation Patterns of G.